Breast metastases of malignant melanoma
PDF
Cite
Share
Request
Case Reports
VOLUME: 27 ISSUE: 1
P: 53 - 54
March 2011

Breast metastases of malignant melanoma

Turk J Surg 2011;27(1):53-54
1. Dr. Süreyya Adanalı Göksun Devlet Hastanesi, Genel Cerrahi, Kahramanmaraş, Türkiye
2. Ankara Onkoloji Eğitim ve Araştırma Hastanesi, Genel Cerrahi, Ankara, Türkiye
3. Erciyes Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Kayseri, Türkiye
No information available.
No information available
PDF
Cite
Share
Request

Abstract

We aimed to analyze a case of breast metastases from cutaneous malignant melanoma with the literature findings. After performing lumpectomy for the metastatic mass, the patient received oral temozolamide. Four months after the therapy of metastatic disease patient died. Since breast metastases of malignant melanoma are rare, they are reported as a marker of disseminated disease. Agressive surgical procedures are unneccesary. Lumpectomy or quadrantectomy seems to be sufficent surgical procedures. Chemotherapy regimens for metastatic malignant melanoma have been thought as useless.

Keywords:
Breast metastases, melanoma, temozolamide

References

1
Clunie GJA, Devitt P. Textbook of Surgery. 3th ed. Massachusetts: Blackwell Publishing, 2006: 366-368.
2
Barnett CC, Sussman JJ, Gershenwald JE. The M.D. Anderson Surgical Oncology Handbook. 3th ed. Phiadelphia: Lippincott Williams & Wilkins,2003:41-78.
3
Cuevasa JD, Whitman E. The Washington Manual of Oncology. 1st ed. Phiadelphia: Lippincott Williams & Wilkins,2002:338-348.
4
Ünal A. Klinik Cerrahi Onkoloji. 1st ed. Ankara: Özkan Matbaacılık, 1997:322-335.
5
Aksu G, İnan N, Uthan Z. İleri evre malign melanomda meme parankim metastazı: olgu Sunumu. Türk Onkoloji Dergisi 2007;22:35-37.
6
Mathew M, Burney IA, Hamadani AA, Rao K. Bilateral breast metastases in a pregnant woman with disseminated cutaneous melanoma. Indian J Cancer 2009;46:342-344.
7
Arribas del amoD, Santero RHP, Cordoba DL, Martinez UF, Subias CM, Diarte A. Breast metastases. Clin Transl Oncol 2005;7:455-457.
8
Yeh CN, Lin CH, Chen MF. Clinical and ultrasonographic characterisitcs of breast metastases from extramammary malignencies. Am Surg 2004;710: 287-290.
9
Ravdel L, Robinson WA, Lewis K, Gonzalez R. Metastatic melanoma in the breast: a report of 27 cases. J Surg Oncol 2006;94:101-104.
10
Jayalakshmi S, Chander S, Prasad RR, Saxena AK, Sharma MC, Rat GK. Malignant melanoma presenting as bilateral breast masses. Australas Radiol 1997;41:38-40.
11
Wierrani F, Kubista E, Czerwenka K. Metastatic spread of extramammary malignant melanomas to the female breast and the clinical consequences. Zentralbl Gynakol 1988;110:1174-1178.
12
Argia R, Robinson WA. Breast metastases from malignant melanoma. J Surg Oncol 1992;50:27-29.
13
Plesnicar A, Kovac V. Breast metastases from cutaneous melanoma: a report of three cases. Tumori 2000;86:170-173.
14
Loffeld A, Marsden JR. Management of melanoma metastases to the breast: case series and review of the literature. Br J Dermatol 2005;152:1206-10.
15
Yoon C, Papadopoulos NE, Camacho LE, McIntyre S, Alvarado GC, Bedikian AY, Hwu P, Kim KB. The clinical efficacy of combination of docetaxel and temozolomide in previously treated patients with stage IV melanoma. Melanoma Res 2010; 20:43-47. [DOI:10.1097/ CMR.0b013e3283324e2e]
16
Siena S, Crino L, Danova M, Del Prete S, Cascinu S, Salvagi S, Schiavetto I, Vitali M, Bajetta E. Dose-dense temozolomide regimen for the treatment of brain metastases from melanoma, breast cancer, or lung cancer not amenable to surgery or radiosurgery: a multicenter phase II study. Ann Oncol 2010;21:655-661.
17
Wierzbicka E, Sassalos B, Mourey L, Guillot B, Bedane C, Guillet G, Tourani JM. Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of phase II multicenter trial. Melanoma Res 2010; 20:141-146.
18
Schild SE, Behl D, Markovic SN, Brown PD, Sande JR, Deming RL, Rowland KM Jr, Bearden JD. Brain metastases from melanoma: Is there a role for concurrent temozolomide in addition to whole brain radiation therapy? Am J Clin Oncol; 2010; 33: 633-636. [DOI:10.1097/ COC.0b013e3181c4c54b]
19
Clarck JI, Moon J, Hutchins LF,Somsan JA, Kast WM, Da Silva DM, Liu PY, Thompson JA, Flaherty LE, Sondak VK . Phase 2 trial of thalidomide plus temozolomide in patients with metastatic malignant melanoma. Cancer 2009;116: 424-431.